What is the name of your organization?
Heamac Inc
What is the name of your solution?
nLite360®
Provide a one-line summary or tagline for your solution.
Revolutionizing neonatal jaundice treatment with AI-driven, adaptive phototherapy for improved efficacy, speed, and global accessibility.
In what city, town, or region is your solution team headquartered?
1320 Arncliffe Pl, Windsor, Ontario N8S 4K3, Canada
In what country is your solution team headquartered?
CAN
What type of organization is your solution team?
For-profit, including B-Corp or similar models
Film your elevator pitch.
What specific problem are you solving?
We are addressing a critical gap in neonatal care—the lack of real-time, adaptive, and efficient treatment for severe neonatal jaundice.
Neonatal jaundice affects up to 80% of newborns globally, and while many cases are mild, a significant percentage require urgent and precise treatment. Despite the availability of phototherapy in Europe and North America, the current standard of care faces key challenges:
Lack of real-time bilirubin monitoring, resulting in under- or over-treatment.
No adaptive or personalized treatment protocols—therapy is often uniform, ignoring each infant’s unique risk profile.
High rates of hospital readmissions, especially in Canada and the U.S., due to jaundice-related complications.
Limited continuity of care post-discharge, putting infants at risk when follow-up is delayed or inconsistent.
Phototherapy units are often non-portable, bulky, and require experienced staff, which restricts home-based or decentralized treatment options.
In rural, remote, or Indigenous communities across Canada, these problems are further magnified:
Long distances to hospitals, often hours away.
Limited access to neonatal specialists or NICUs.
Healthcare inequities that leave families dependent on costly transfers or delayed interventions.
Our solution is designed to integrate seamlessly into modern hospital settings and rural, Indigenous communities ensuring equity, accessibility, and clinical excellence in neonatal jaundice treatment
What is your solution?
nLite360® is a breakthrough AI-powered, robotic phototherapy device transforming neonatal jaundice treatment across Canada and North America. Designed for precision, portability, and accessibility, it bridges care gaps from advanced NICUs to rural and Indigenous communities with limited neonatal resources.
Unlike conventional phototherapy, nLite360 dynamically adapts treatment based on real-time bilirubin monitoring, following AAP guidelines and Bhutani risk charts, ensuring accurate, personalized care while minimizing risks of over- or under-treatment.
Compact and lightweight, the device is ideal for urban hospitals, community clinics, and even home-based care—enabling treatment closer to home for families in underserved or remote areas. Its intuitive interface and automation allow minimally trained healthcare workers to operate it safely, expanding its reach to settings lacking pediatric specialists.
nLite360 integrates remote monitoring for seamless, clinician-led oversight and supports Kangaroo Mother Care, promoting bonding and faster recovery. With up to 3x faster bilirubin reduction than traditional devices, it reduces hospital stays, readmissions, and costs.
Headquartered in Canada, we are committed to supporting national goals of health equity, Indigenous health inclusion, and universal access. By merging intelligent automation with inclusive design, nLite360 is redefining the global standard in neonatal jaundice care—a Canadian innovation with worldwide impact.
Who does your solution serve, and in what ways will the solution impact their lives?
nLite360® serves newborns, families, and healthcare providers across a broad spectrum from urban hospitals to rural and Indigenous communities in Canada and North America.
At its core, our solution is built to serve:
1. Newborns with Jaundice
nLite360 provides accurate, real-time, and personalized phototherapy, reducing the risk of brain damage, disability, or death due to under- or over-treatment. Faster recovery leads to shorter hospital stays and improved long-term outcomes for infants.
2. Parents and Families
By enabling safe, decentralized, and even home-based care, nLite360 eases emotional and financial stress on families—especially those in remote or underserved areas. With features like Kangaroo Mother Care support and remote monitoring, parents can stay close to their child and actively participate in the care journey.
3. Healthcare Providers and Systems
nLite360 empowers clinicians and nurses—regardless of specialization level—to deliver high-quality neonatal care using its intuitive, automated interface. This reduces dependence on highly specialized staff, especially critical in rural and low-resource settings. The device also helps hospitals reduce readmissions, improve outcomes, and lower operational costs.
In essence, nLite360® brings equitable, intelligent, and accessible neonatal care to those who need it most—saving lives, strengthening families, and supporting healthcare systems across Canada and beyond.